These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23918758)

  • 21. Far-field oversensing of atrial signals: an unusual cause for very short V-V intervals and inappropriate implantable cardioverter defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2008 Aug; 10(8):1009-11. PubMed ID: 18424788
    [No Abstract]   [Full Text] [Related]  

  • 22. Charge circuit timeout: a sequence of events leading to failure of an implantable cardioverter-defibrillator to deliver therapy.
    Catanzaro JN; Kim J; Patel A; Slotwiner D; Goldner B
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):e33-5. PubMed ID: 21846878
    [No Abstract]   [Full Text] [Related]  

  • 23. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 24. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avoidance of electromagnetic interference to implantable cardiovertor-defibrillator during atrioventricular node ablation for atrial fibrillation using transvenous cryoablation.
    Siu CW; Tse HF; Lau CP
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):914-6. PubMed ID: 16923011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
    Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
    Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy.
    Theuns DA; Klootwijk AP; Simoons ML; Jordaens LJ
    Am J Cardiol; 2005 Jan; 95(2):271-4. PubMed ID: 15642568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of implantable cardioverter defibrillator therapy during magnetic resonance imaging.
    Nemec J
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):444-5. PubMed ID: 16643373
    [No Abstract]   [Full Text] [Related]  

  • 30. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators.
    Santini M; Gasparini M; Landolina M; Lunati M; Proclemer A; Padeletti L; Catanzariti D; Molon G; Botto GL; La Rocca L; Grammatico A; Boriani G;
    J Am Coll Cardiol; 2011 Jan; 57(2):167-72. PubMed ID: 21211688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter-defibrillator system in patients without antibradycardia pacing indications: results of a randomized study.
    Sticherling C; Zabel M; Spencker S; Meyerfeldt U; Eckardt L; Behrens S; Niehaus M;
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):56-63. PubMed ID: 21156772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular and supraventricular arrhythmias and heart failure in a patient with left ventricular noncompaction and Brugada syndrome.
    Kaźmierczak J; Zielonka J; Peregud-Pogorzelska M; Kiedrowicz R; Wielusiński M
    Cardiol J; 2011; 18(3):310-3. PubMed ID: 21660923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Failure to detect ventricular fibrillation in a patient with an implantable cardioverter-defibrillator].
    Antolinos-Pérez MJ; García-Alberola A; Redondo-Bermejo B; Valdés-Chávarri M
    Rev Esp Cardiol; 2006 May; 59(5):517-8. PubMed ID: 16750153
    [No Abstract]   [Full Text] [Related]  

  • 37. Every cloud has a silver lining: a case of simultaneously appropriate and inappropriate implantable cardioverter defibrillator shock.
    Capulzini L; Mazzotta G; Sorgente A
    Europace; 2013 Nov; 15(11):1683. PubMed ID: 23507819
    [No Abstract]   [Full Text] [Related]  

  • 38. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remote monitoring for prevention of inappropriate implantable cardioverter defibrillator shocks: is there no place like home?
    Marine JE
    Europace; 2009 Apr; 11(4):409-11. PubMed ID: 19221101
    [No Abstract]   [Full Text] [Related]  

  • 40. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.